ArticleMolecular cancer2024

Correction: Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the "all-around warrior" in immunotherapy.

Qiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.